Shreeman Diagno Plast India Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 18-07-2024
- Paid Up Capital ₹ 6.54 M
as on 18-07-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.40 M
as on 18-07-2024
- Revenue -27.28%
(FY 2020)
- Profit -221.43%
(FY 2020)
- Ebitda 262.48%
(FY 2020)
- Net Worth -198.56%
(FY 2020)
- Total Assets -0.67%
(FY 2020)
About Shreeman Diagno Plast India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.54 M.
The company currently has active open charges totaling ₹2.40 M.
Jayashree Laxman and Laxman Vaman serve as directors at the Company.
- CIN/LLPIN
U25209TG2009PTC065882
- Company No.
065882
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shreeman Diagno Plast India Private Limited offer?
Shreeman Diagno Plast India Private Limited offers a wide range of products and services, including Laboratory Glassware, Laboratory Dishes, Petri Dish, Laboratory Plasticware, Urine Containers, Specimen Containers, Plastic & Glass Labware, Glass Slides, Laboratory Plates, Laboratory & Lab Equipment.
Who are the key members and board of directors at Shreeman Diagno Plast India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxman Vaman  | Director | 19-Nov-2009 | Current |
| Jayashree Laxman | Director | 19-Nov-2009 | Current |
Financial Performance and Corporate Structure Insights of Shreeman Diagno Plast India.
Shreeman Diagno Plast India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 27.28% decrease. The company also saw a substantial fall in profitability, with a 221.43% decrease in profit. The company's net worth observed a substantial decline by a decrease of 198.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shreeman Diagno Plast India?
In 2019, Shreeman Diagno Plast India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Hyderabad Creation Date: 28 Jun 2010 | ₹2.40 M | Open |
How Many Employees Work at Shreeman Diagno Plast India?
Shreeman Diagno Plast India has a workforce of 0 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of Jan 20, 2016, Shreeman Diagno Plast India has raised a total of ₹ 6.44 M, with the most recent deal valued at ₹ 2.1 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
